Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ガレクチン-3の免疫アッセイ
Document Type and Number:
Japanese Patent JP2012507724
Kind Code:
A
Abstract:
The present invention relates to methods and compositions for specifically and quantitatively detecting galectin-3 in a sample. Embodiments of the invention include a detection assay in which a capture binding moiety and a labeled binding moiety specifically recognize non-overlapping epitopes on the N-terminus of galectin-3. Further embodiments are directed to a method for establishing ranges of galectin-3 concentrations indicative of the presence and severity of heart failure in a subject and a method for predicting the clinical outcome of a subject based upon galectin-3 concentration.

Inventors:
Muntendam, Peter
Application Number:
JP2011534781A
Publication Date:
March 29, 2012
Filing Date:
October 29, 2009
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BG Medicine, Incorporated
International Classes:
G01N33/53; G01N33/532; G01N33/535; C07K14/47
Domestic Patent References:
JP2004198313A2004-07-15
JP2007508527A2007-04-05
Other References:
JPN6007000954; Cvejic, D., et al.: 'Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue' Anticancer Research Vol.18, 1998, p.2637-2641
JPN6014009256; van Kimmenade RR, Januzzi JL Jr, Ellinor PT, Sharma UC, Bakker JA, Low AF, Martinez A, Crijns HJ, Ma: 'Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation o' J Am Coll Cardiol. Vol.48,No.6, 200609, Page.1217-1224
JPN6014009255; Takenaka Y, Fukumori T, Raz A.: 'Galectin-3 and metastasis.' Glycoconj J. Vol.19, 2004, Page.543-549
JPN6014054946; Matarrese P, Fusco O, Tinari N, Natoli C, Liu FT, Semeraro ML, Malorni W, Iacobelli S.: 'Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties.' Int J Cancer. Vol.85,No.4, 20000215, Page.545-554
Attorney, Agent or Firm:
Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita